Healthcare
Do the New Obesity Drugs Pay for Themselves?
Could expensive drugs like Ozempic save healthcare systems money by reducing the risk of obesity-associated diseases? A new study co-authored by Yale SOM’s Jason Abaluck suggests that other health expenses may actually increase over the first couple years of treatment.
Making healthcare accountable
Sostena Romano sees herself as responsible for producing results for both stakeholders and shareholders in the Clinton Foundation’s HIV/AIDS initiative.